All News about Regeneron Pharmaceuticals
FDA Approves Regeneron's Drug For Ultra Rare Immune Disorder
August 21, 2023
Via Benzinga
Exposures
Product Safety
FDA Approves Regeneron Pharmaceuticals' Higher Dose Of Eylea For Age-Related Blindness
August 21, 2023
Via Benzinga
Exposures
Product Safety
18 Analysts Have This to Say About Regeneron Pharmaceuticals
August 16, 2023
Via Benzinga
Via Benzinga
This Is What Whales Are Betting On Regeneron Pharmaceuticals
August 14, 2023
Via Benzinga
This Is What Whales Are Betting On Regeneron Pharmaceuticals
August 10, 2023
Via Benzinga
(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest
August 04, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|